Stocks Listing
AUPH

Aurinia Pharmaceuticals Inc.

Share
AUPH
$7.04 3.03%Last Updated Sep 23 2022 07:56 PM
1D Low / 1D High
Low:$6.66
High:$7.16
1D
3.03%
5D
4.61 %
30D
11.67 %
BulletPurple
Market Cap
$998,210,176
3.1 %
1 B
BulletBlue
Volume 1D
2,603,919
-
2.6 M
BulletOrange
Circulating Supply
141,891,994 AUPH
141.9 M

Price Chart

1D
5D
1M
6M
YTD
1Y
MAX
About

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open - Close
Low/High
Volume
Market Cap
Show More
Market Status
Closed
NGM
NASDAQ Stock Exchange
USA
Opens in
10 hours, 33 minutes
Working Hours
Mon-Fri, 01:30 PM - 08:00 PM
Timezone
GMT+0